Other
Zimmer Biomet Holdings·Income Statement·7 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.8B | $2B | $1.9B | $2.1B | $2B | $2.2B | $2.1B |
| Amortization of capitalized software and acquired intangible assets | $144M | $148.2M | $157.6M | $151M | $160.6M | $176.5M | $177.7M | $162.1M |
| Research and development expense | $109.4M | $111.6M | $108.5M | $110.6M | $113.3M | $115.9M | $118.7M | $103.4M |
| Interest Income (Expense), Operating | -$51.1M | -$54.3M | -$61.9M | -$66.2M | -$79.3M | -$75.4M | -$71.9M | -$68.8M |
| Acquisition Integration Divestiture And Related Expenses | $5.2M | $4.4M | $13.7M | $10.6M | $78.9M | -$34.4M | $21.9M | $15.6M |
| Restructuring And Other Cost Reduction Initiatives | $41.5M | $32.2M | $20.9M | $36M | $17.5M | $21.4M | $106.3M | $6.3M |
| Other income, net (Note 6) | $2M | $5.1M | -$38.1M | $2.9M | $3.9M | $3.3M | $15.4M | -$3M |